Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 1/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.34 |
| ▸ | RORC | P51449 | 1/20 | 0.32 |
| ▸ | KIT | P10721 | 3/20 | 0.32 |
| ▸ | SMO | Q99835 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.31 |
| ▸ | ATXN2 | Q99700 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30675655 | 0.88 | PDE4B (0.34) | PDE4BRORCKITSMOHRH3 | |
| SCHEMBL26961607 | 0.88 | PDE4B (0.34) | PDE4BRORCKITSMOHRH3 | |
| SCHEMBL26962059 | 0.87 | S1PR1 (0.32) | PDE4BRORCKITPARP1 | |
| SCHEMBL26961851 | 0.86 | KIT (0.32) | RIPK1KITHRH3 | |
| SCHEMBL26961925 | 0.81 | RIPK1 (0.32) | RIPK1KIT | |
| SCHEMBL26962068 | 0.78 | S1PR1 (0.33) | PDE4BRORCKITPARP1 | |
| SCHEMBL26962145 | 0.78 | S1PR1 (0.33) | RIPK1PDE4BRORCKITPARP1 | |
| SCHEMBL26962067 | 0.76 | PDE4B (0.32) | PDE4BRORCPARP1 | |
| SCHEMBL26961820 | 0.75 | KIT (0.34) | KIT | |
| SCHEMBL26961853 | 0.74 | PDE4B (0.38) | PDE4BSMOHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4291558-A1 | BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER | F. Hoffmann-La Roche AG (CH) | 2023-12-20 | — | — | EP | disclosed |